Skyepharma Cash Flow - Quarterly (OTCMKTS:SKYEY)

Add to My Stocks
$6.28 $0.02 (0.32%) SKYEY stock closing price Jun 24, 2016 (Closing)

The financial analysis of SKYEY requires an investor to check the cash flows for Skyepharma. While its important to look at the Skyepharma debt position, the cash flow statement becomes equally important because public companies use accrual accounting. For example, if a company sells a product which gets counted as Skyepharma revenue but does not convert to cash because it does not receive payment in the same quarter, it affects the cash position for that period. Skyepharma had cash and cash equivalents of $58.8M at beginning of the quarter and $62.83M at quarter end of 2015 Q4. Skyepharma cash flow analysis tells whether or not the company has enough cash for its day to day activities, and for investing for future growth. Skyepharma has a positive cash and cash equivalents change of $13.3M.

View and download details of Skyepharma cash flows for latest & last 40 quarters
show more
Fiscal year is Jan - Dec2015 Q4
Net Income Cash Flow
40.21M
Depreciation Depletion Amortization Cash-Flow4.28M
Net Increase (Decrease) in Assets Liabilities-14.37M
Cash From (used in) Discontinued Operations-
Other Adjustments Net8.4M
Net Cash from (used by) Operating Activities
38.52M
Increase (Decrease) in Prop Plant And Equipment-5.35M
Acquisition Disposition of Subsidiaires-
Increase (Decrease) in Investments-
Other Cash Inflow (Outflow) from Investment Activities-1.37M
Net Cash from (used by) Investment Activities
-6.72M
Issuance (Purchase) of Equity Shares-
Issuance (Repayment) of Debt Securities-17.27M
Increase (Decrease) in Bank & Other Borrowings-
Payment of Dividends & Other Cash Distributions-
Other Cash from (used by) Financing Activities-2.59M
Net Cash from (used by) Financing Activities
-19.87M
Effect of Exchange Rate Changes on Cash1.37M
Net Change in Cash & Cash Equivalents
13.3M
Cash & Equivalents at Beginning of Year58.8M
Cash & Equivalents at Year End62.83M
All figures in USD. M: Millions of USD, B: Billions of USD.

The statement of cash flows comprises of cash flow from financing, cash flow from operations and cash flow from investing activities. All the three can have an impact on the stock price. The Skyepharma stock price history and Skyepharma stock comparison chart inevitably reflect its cash flow situation.

  • Skyepharma has cash of $62.83M on hand. A healthy amount of cash on hand is necessary for any company. Cash has an opportunity cost associated with it, and too much cash in bank may mean that the firm has no or limited growth plans. Hence its important to track the Net Change in Cash and Cash Equivalents along with the Skyepharma stock price.
  • Skyepharma increased its cash from operating activities to $38.52M till 2015 Q4. Operating activities include production of goods or creating a product or providing a service, and collecting payment for the same from customers. The cash generated from these activities is refered to as cash flow from operating activities.
  • Growth companies, typically most tech companies; spend heavily on investing activities and this figure stood at $-6.72M for SKYEY stock. Sometimes a company might have a negative overall cash flow which may not be really bad if it is due to investment expenses. Hence it is important to check the cash flow from investment activities.
  • Inflow of cash in the form of bank loans and shareholders equity, and outflow of cash because of dividend payments, share repurchase payments etc. come under financing activities. The cash generated from these activities was $-19.87M for Skyepharma.